Notice: This company has been marked as potentially delisted and may not be actively trading. Zogenix (ZGNX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Needle-Free Drug Injection Systems Business Analysis Report 2023-2030 Featuring AKRA Dermojet, Crossject, D`Antonio Consultants, PharmaJet, and ZogenixAugust 1, 2024 | globenewswire.comHwasung Industrial Co Ltd 002460March 23, 2024 | morningstar.comAlcon (NYSE: ALC)July 6, 2023 | fool.comLongeveron Inc Ordinary Shares - Class AMay 21, 2023 | morningstar.comHow Women Lead #GetonBoard Week Honorees Are Helping Catapult Fearless Women Leaders into Board Seats - Business WireOctober 11, 2022 | businesswire.comBiocryst PharmaceuticalsSeptember 30, 2022 | forbes.comNippon Shinyaku : Fintepla® (fenfluramine) Approved in Japan for the Treatment of Seizures Associated with Dravet syndrome - Marketscreener.comSeptember 26, 2022 | marketscreener.comPROMIS NEUROSCIENCES INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.comSeptember 13, 2022 | marketscreener.comHow Women Lead appoints three new executive board members - Bizwomen - The Business JournalsSeptember 10, 2022 | bizjournals.comEast Bay Biotech Companies - San Francisco Business Times - The Business JournalsSeptember 9, 2022 | bizjournals.comOncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors - PR NewswireSeptember 9, 2022 | prnewswire.comOncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors - StreetInsider.comSeptember 8, 2022 | streetinsider.comOncolytics Biotech® Appoints Jonathan Rigby to its Board of Directors - Yahoo FinanceSeptember 7, 2022 | finance.yahoo.comWith early-cancer detection technology, Delfi Diagnostics looks to beat out Guardant Health, Illumina's Grail and others - San Francisco Business Times - The Business JournalsAugust 30, 2022 | bizjournals.comDepomed Reports Dip in Earnings, Reduces Revenue GuidanceAugust 29, 2022 | thestreet.comDelfi Diagnostics Adds Finance and Market Access Leadership as It Prepares for Commercial Launch - PR NewswireAugust 23, 2022 | prnewswire.comNuvig Therapeutics Expands Leadership Team with the Appointment of Dr. Joanne Quan as Chief Medical Officer - Business WireAugust 16, 2022 | businesswire.comNuvig Therapeutics Expands Leadership Team with the Appointment of Dr. Joanne Quan as Chief Medical Officer - StreetInsider.comAugust 15, 2022 | streetinsider.comDravet Syndrome Treatment Market Report 2022-2029: Stiripentol and Cannabidiol to Contribute to Significant Growth of 11.7% - ResearchAndMarkets.com - Business WireAugust 9, 2022 | businesswire.comTevard Biosciences Appoints Zoya Ignatova to Its Scientific Advisory Board - StreetInsider.comAugust 3, 2022 | streetinsider.comGeno Hires First Chief Legal Officer on Path to Accelerate the Transition to More Sustainable Materials - PR NewswireAugust 2, 2022 | prnewswire.comUCB : Strong first six months – UCB with continued delivery and strong resilience - Marketscreener.comJuly 28, 2022 | marketscreener.comAdamis Appoints Vickie Reed to Board of Directors - GuruFocus.comJune 25, 2022 | gurufocus.comUCB : updates financial guidance for 2022 while maintaining 2025 financial guidance - Marketscreener.comJune 24, 2022 | marketscreener.comADARx Pharmaceuticals Expands Leadership Team, Appointing Andrew Seacat as Head of Toxicology - Business WireJune 8, 2022 | businesswire.comUCB's therapy gets FDA orphan drug status to treat seizures linked with rare epilepsy - Seeking AlphaJune 8, 2022 | seekingalpha.comADARx Pharmaceuticals Expands Leadership Team, Appointing Andrew Seacat as Head of Toxicology - StreetInsider.comJune 7, 2022 | streetinsider.comAdamis Appoints Vickie Reed to Board of Directors - StreetInsider.comMay 27, 2022 | streetinsider.comSuneva Medical Inc. Announces Multiple Regulatory Approvals in the U.S. and CanadaMay 6, 2022 | markets.businessinsider.comNorton Rose Adds Brussels Antitrust Pro From Covington - Law360April 19, 2022 | law360.comU.S. FDA approves UCB's drug for rare childhood epilepsy - Marketscreener.comMarch 28, 2022 | marketscreener.comU.S. FDA approves UCB's drug for rare childhood epilepsy - Reuters.comMarch 28, 2022 | reuters.comForm POS AM ZOGENIX, INC. - StreetInsider.comMarch 7, 2022 | streetinsider.comUCB completes $1.9B acquisition of Zogenix - Seeking AlphaMarch 7, 2022 | seekingalpha.comUCB Completes Acquisition of Zogenix, Inc. - Benzinga - BenzingaMarch 7, 2022 | benzinga.comUCB Completes Acquisition of Zogenix, Inc. - PR NewswireMarch 7, 2022 | prnewswire.comUCB Completes Acquisition of Zogenix, Inc.March 7, 2022 | finance.yahoo.comZogenix : Amendment to Annual Report (Form 10-K/A) - Marketscreener.comMarch 7, 2022 | marketscreener.comTrading was temporarily halted for "ZGNX" at 07:03 PM with a stated reason of "News pending."March 7, 2022 | marketbeat.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022 - Yahoo FinanceMarch 6, 2022 | finance.yahoo.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN - BenzingaMarch 4, 2022 | benzinga.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022 - StreetInsider.comMarch 4, 2022 | streetinsider.comZogenix To Present New Long-term Data On FINTEPLA (fenfluramine) In Lennox-Gastaut Syndrome (LGS) At AAN 2022 From April 2-7 - BenzingaMarch 4, 2022 | benzinga.comZogenix To Present New Long-term Data on FINTEPLA® - GlobeNewswireMarch 4, 2022 | globenewswire.comZogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022March 4, 2022 | finance.yahoo.comZogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results - Yahoo FinanceMarch 2, 2022 | finance.yahoo.comZOGENIX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K) - Marketscreener.comMarch 1, 2022 | marketscreener.comUCB Announces Extension of Tender Offer to Acquire Zogenix, Inc. - marketscreener.comMarch 1, 2022 | marketscreener.comZogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results - GlobeNewswireMarch 1, 2022 | globenewswire.comRecap: Zogenix Q4 Earnings - BenzingaFebruary 28, 2022 | benzinga.com Get Zogenix News Delivered to You Automatically Sign up to receive the latest news and ratings for ZGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… ZGNX Media Mentions By Week ZGNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZGNX News Sentiment▼0.200.59▲Average Medical News Sentiment ZGNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZGNX Articles This Week▼00▲ZGNX Articles Average Week Get Zogenix News Delivered to You Automatically Sign up to receive the latest news and ratings for ZGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CORT News PRGO News SUPN News PCRX News OMER News NKTR News ASMB News CPIX News LLY News JNJ News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZGNX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zogenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZGNX Stock Alerts